Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

RNA Editing02:23

RNA Editing

9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

114
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
114
Epigenetic Regulation01:37

Epigenetic Regulation

3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Types of RNA01:20

Types of RNA

6.3K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
6.3K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
8.5K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The strategic importance of mRNA vaccine technologies in Africa for achieving public health independence.

Communications medicine·2026
Same author

Three-dimensional culture models of hepatitis B virus infection: Progress, challenges, and opportunities.

Virology·2026
Same author

Precision control of cardiac mitochondrial bioenergetics: Therapeutic prospects of CRISPR-Cas9 activators.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

CD20 tails interact with the 14-3-3/GEF-H1 complex and microtubule network upon PKCδ phosphorylation.

The EMBO journal·2026
Same author

Structural mimics of SARS-CoV-2.

Infection·2026
Same author

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Frontiers in genome editing·2025
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 9, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.8K

抗HBV設計エピジェノーム修正剤を生成するmRNA

Prashika Singh1, Tafadzwa Mlambo2, Kristie Bloom1

  • 1Wits/SAMRC Antiviral Gene Therapy Research Unit, Infectious Diseases and Oncology Research Institute (IDORI), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Methods in molecular biology (Clifton, N.J.)
|August 28, 2025
PubMed
まとめ
この要約は機械生成です。

新しいエピゲノム編集ツールは,mRNAによって提供される設計エピゲノム修正剤 (DEM) を使用して,慢性B型肝炎ウイルス (HBV) の複製を標的と沈黙させます. このアプローチは HBV 治療の持続的な非変異性戦略として有望です

キーワード:
CpG島DEM についてHBV ウイルスインビトロ転写

さらに関連する動画

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.2K

関連する実験動画

Last Updated: Sep 9, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.8K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.2K

科学分野:

  • エピジェネティクス
  • ウイルス学
  • 分子生物学

背景:

  • B型肝炎ウイルス (HBV) の慢性的な感染は,世界中で2億5千7百万人以上が罹患しており,肝臓疾患による重大な死亡率を引き起こしています.
  • 現在の抗ウイルス治療は,持続的なHBV共性閉じた円形DNA (cccDNA) 貯蔵庫を排除する能力に制限があります.
  • エピゲノム編集は,ウイルスの遺伝子発現を標的とする新しい非変異性戦略を提示します.

研究 の 目的:

  • HBVの標的型エピジェネティックサイレンシングのためのmRNAエンコードされたデザインエピゲノム修正剤 (DEM) の開発と評価.
  • 免疫刺激性二鎖RNA (dsRNA) を除去することによってmRNAの産生を最適化する.
  • 細胞培養におけるHBVDNAのDEM媒介による転写抑制の有効性を評価する.

主な方法:

  • 主要なHBVオープンリーディングフレーム (ORF) のCpG島をメチル化するために設計されたmRNAエンコーディングDEMの生成.
  • pT7 ((AG)) プラットフォームからのDEM配列のインビトロ転写.
  • dsRNAの汚染物質を取り除くためにmRNAを浄化し,発現を促進する.
  • 培養細胞を合成されたmRNAで感染させ,HBV DNAの転写抑制を評価する.

主要な成果:

  • HBV エピゲノム改変のために設計されたmRNAをコードするDEMの成功合成.
  • dsRNA除去プロトコルによって達成されたmRNA発現の改善.
  • 培養細胞におけるHBVDNAの標的型転写抑制がDEMによって示された.

結論:

  • mRNAによるDEMは,慢性HBVのエピジェネティックサイレンシングの有効な戦略です.
  • このアプローチは,他の遺伝子編集技術に関連するゲノム統合とオフターゲット効果のリスクを最小限に抑えます.
  • 慢性 HBV 感染症において,エピジェネティック・セラピーは持続的な治療効果をもたらす可能性があります.